Technology Forums

Want to host a Technology Forum at the 2017 CRS Annual Meeting? Learn more.

These forums are open to all registered attendees on a complimentary basis, offering in-depth coverage of controlled release technologies and services. hosted by the following companies.

Sunday, July 16, 2017

9:00 a.m. - 1:00 p.m. • Each session lasts one hour

 




Changing the Culture of Dissolution Qualification
12:00 – 1:00 p.m. – Room Beacon F
Presenter: Dan Spisak
Presentation Areas: Formulation, Quality & Analytical
We’ve witnessed significant changes in the dissolution laboratory over the past few years. Current regulations and available devices present dissolution laboratories with a tremendous opportunity. Is anyone capitalizing on this? Learn how to prevent qualification failures and reduce investigations by taking a fresh approach to qualification of your dissolution instrumentation.
Company website: www.agilent.com

 

 

Silicones for Controlled Release Applications
10:30 – 11:30 a.m. – Room Beacon E
Presenter: Matthew Kihara
Presentation Areas: Formulation, Processing
Presentation will be done in partnership with ProMed Pharma and will cover 1) silicone chemistry, 2) types of silicones and their properties, 3) compounding/mixing, 4) molding/extrusion, 5) formulation with APIs, and 6) controlled release applications.
Company website: www.bluestarsilicones.com

 

 

The Patient Perspective – Avenues to Better Success in Late Phase Clinical Studies and Validated Patient Data
9:00 – 10:00 a.m. – Room Beacon D
Presenter: Uri Baruch
Presentation Area: Formulation
Discussion on how the use of technology can assist in ensuring greater patient adherence in phase 2 and 3 clinical trials and how the data gathered during the trial can be used to design better devices as well as medication regime.
Company website: www.cambridge-design.co.uk

 

 

AFFINISOL™ Innovative Polymer Solutions for Solubility
9:00 – 10:00 a.m. – Room Beacon G
Presenter: Charles Vesey and William Porter III
Presentation Area: Formulation
An increasing number of active pharmaceutical ingredients suffer from low solubility. To address this issue, Dow developed AFFINISOL™ hypromellose and hypromellose acetate succinate to enable solubility enhancement via hot melt extrusion and spray drying applications. This presentation will highlight the utility of these excipients to form stable amorphous solid dispersions.
Company website: www.colorcon.com

 

How to Better Control Pellet Production Processes Through Counting
10:30 – 11:30 a.m. – Room Beacon F
Presenter: Yosi Shiloni
Presentation Areas: Formulation, Quality & Analytical, Processing
Drug developers and capsule producers are facing a great challenge: how to better control the required active material that is used during the pellet coating process. For answering this challenge, DATA developed a unique solution (DATA Count PH-JR) that quickly and accurately counts pharmaceutical pellets and mini-tablets as small as 0.25 mm.
Company website: www.data-technologies.com

 



The Role Liposomes, Nanoparticles, and Microparticles Play in Parenteral Drug Delivery and Patient Care
10:30 – 11:30 a.m. – Room Beacon D
Presenters: Thomas Tice and Norbert Maurer
Presentation Area: Formulation
Complex parenteral formulations include liposomes, nanoparticles, and extended-release microparticles. Established formulation techniques will play key roles in the future delivery of drugs and vaccines based on peptides, proteins, and nucleic acids. They will facilitate newer therapeutic approaches including immunotherapies, gene silencing, and local and targeted delivery. This presentation reviews liposome, nanoparticle, and microparticle based drug delivery approaches and their future impact on patients and healthcare providers.
Company website: www.evonik.com/healthcare

 

EUDRATEC®: Innovative Formulation Technologies for Advanced Oral Drug Delivery
12:00 – 1:00 p.m. – Room Beacon E
Presenter: Firouz Asgarzadeh
Presentation Area: Formulation
When conventional oral drug delivery technologies fail, Evonik’s EUDRATEC® technologies can provide robust modified release coating platforms for oral delivery of APIs in a myriad of challenging applications including resistance to alcohol-induced dose dumping, precise time release, zero order release, pulse release, BCS III/IV bioavailability enhancement, and delivery of biologics such as peptides and proteins.
Company website: www.evonik.com/healthcare

 

 

What You Should Know About Lipid-Based Formulations: Oral Delivery of Peptides
9:00 – 10:00 a.m. – Room Beacon E
Presenters: Vincent Jannin and Jasmine Musakhanian
Presentation Area: Formulation
In an interesting series of recently published works, model peptides leuprorelin, insulin, and desmopressin were formulated in SEDDS following hydrophobic ion-pairing of the peptides. The newly designed formulations facilitated payloads of >10%  for peptide drugs, provided 100% protection against proteases, reduced glutathione, and improved their intestinal permeability.
Company website: www.gattefosse.com

 


Preclinical Strategies for Differentiated Drug Product Development
12:00 – 1:00 p.m. – Room Beacon D
Presenter: Gopinadh Bhyrapuneni
Presentation Area: Quality & Analytical
In development of differentiated drug products, pharmaceutical companies often outsource animal testing to preclinical CROs for establishing bioequivalence/superiority to the RLD. This presentation will address the strategies for preclinical pharmacokinetic, pharmacodynamic, and toxicokinetic studies of differentiated drug product dosage forms.
Company website: www.suven.com

 

 

High-Throughput or Well-Characterized? Light Scattering Tools for Rapid Screening and Deep Characterization of Therapeutic Nanoparticles
9:00 – 10:00 a.m. – Room Beacon F
Presenter: John Champagne
Presentation Areas: Formulation, Quality & Analytical
Light scattering addresses many key analytical challenges in drug nanoparticle R&D, including accurate size distributions, conformation, payload, and formulation. We review light scattering fundamentals and then present examples illustrating how Wyatt’s unique light scattering instrumentation facilitates rapid and effective development of controlled release vehicles including liposomes, VLPs, polymer-encapsulated nanoparticles, and nanogels.
Company website: www.wyatt.com

© Copyright Controlled Release Society  | Contact Us - Report a Bad Link